Prudential Financial’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
Other funds holding CGON
VPM
VCM
Prudential Financial's CGON Position: Q2 2026 in Review
Prudential Financial increased its CG Oncology (CGON) stake by 451% in Q2 2026, buying an estimated $2.86M and bringing the position to 53,455 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1111.
Prudential Financial first reported a position in CGON in Q3 2025 and has held it in 3 quarters since. 151 funds tracked by Wall St. Rank hold CGON as of Q2 2026.
- Prudential Financial held 53,455 shares of CG Oncology worth $3.8M as of Q2 2026.
- Prudential Financial bought 43,755 CG Oncology shares in Q2 2026, an estimated $2.86M.
- CG Oncology made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1111 holding.
- Prudential Financial first reported a position in CG Oncology in Q3 2025 and has held it in 3 quarters since.
- 151 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.